Stage II Lung Cancer AJCC v8

general

Stage IIA includes: T2b, N0, M0. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.)

77

Centers

246

Active Trials

Cancer Funding

Top Centers for Stage II Lung Cancer AJCC v8(77)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.3
2
High-Volume Research Center
72.3
3
High-Volume Research Center
72.3
4
NCI Comprehensive
Active Research Program
69.4
5
NCI Comprehensive
Active Research Program
69.4
6
NCI Comprehensive
Active Research Program
69.4
7
NCI Comprehensive
Active Research Program
69.4
8
NCI Clinical
Active Research Program
69.4
9
NCI Comprehensive
Active Research Program
69.4
10
Active Research Program
69.4
11
NCI Comprehensive
Active Research Program
66.1
12
NCI Clinical
Active Research Program
66.1
13
Active Research Program
66.1
14
Active Research Program
66.1
15
NCI Comprehensive
Active Research Program
63.8
16
NCI Comprehensive
Active Research Program
63.8
17
NCI Clinical
Active Research Program
63.8
18
Active Research Program
63.8
19
NCI Comprehensive
Active Research Program
60.0
20
NCI Comprehensive
Active Research Program
60.0
21
NCI Comprehensive
Active Research Program
60.0
22
NCI Comprehensive
Active Research Program
60.0
23
NCI Comprehensive
Active Research Program
60.0
24
Active Research Program
60.0
2560.0
26
Active Research Program
60.0
27
Active Research Program
60.0
28
NCI Comprehensive
Active Research Program
53.0
29
NCI Comprehensive
Active Research Program
53.0
30
NCI Comprehensive
Active Research Program
53.0
31
NCI Comprehensive
Active Research Program
53.0
32
NCI Comprehensive
Active Research Program
53.0
33
NCI Comprehensive
Active Research Program
53.0
34
NCI Comprehensive
Active Research Program
53.0
35
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
53.0
36
NCI Comprehensive
Active Research Program
53.0
37
NCI Comprehensive
Active Research Program
53.0
38
Active Research Program
53.0
39
Active Research Program
53.0
40
Active Research Program
53.0
41
Active Research Program
53.0
42
Active Research Program
53.0
43
NCI Comprehensive
Active Research Program
44.5
44
NCI Comprehensive
Active Research Program
44.5
45
NCI Comprehensive
Active Research Program
44.5
46
NCI Comprehensive
Active Research Program
44.5
47
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
44.5
48
NCI Comprehensive
Active Research Program
44.5
49
Active Research Program
44.5
50
Active Research Program
44.5
51
NCI Comprehensive
Active Research Program
44.5
52
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
44.5
53
Active Research Program
44.5
54
Active Research Program
44.5
55
Active Research Program
44.5
56
Active Research Program
44.5
57
NCI Comprehensive
Contributing Research Center
34.6
58
NCI Comprehensive
Contributing Research Center
34.6
59
NCI Comprehensive
Contributing Research Center
34.6
60
NCI Comprehensive
Contributing Research Center
34.6
61
NCI Comprehensive
Contributing Research Center
34.6
62
NCI Comprehensive
Contributing Research Center
34.6
63
NCI Comprehensive
Contributing Research Center
34.6
64
NCI Comprehensive
Contributing Research Center
34.6
65
NCI Comprehensive
Contributing Research Center
34.6
66
NCI Comprehensive
Contributing Research Center
34.6
67
NCI Clinical
Contributing Research Center
34.6
68
NCI Clinical
Contributing Research Center
34.6
69
NCI Comprehensive
Contributing Research Center
34.6
70
NCI Comprehensive
Contributing Research Center
34.6
71
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Contributing Research Center
34.6
72
NCI Comprehensive
Contributing Research Center
34.6
73
NCI Basic_laboratory
Contributing Research Center
34.6
74
Contributing Research Center
34.6
75
Contributing Research Center
34.6
76
Contributing Research Center
34.6
77
NCI Comprehensive
28.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →